Minimally Invasive Micro Sclerostomy (MIMS®) is a Stent-less, Simple and Innovative procedure for Glaucoma treatment, designed to effectively lower the IOP.


MIMS® Story

Dr Douglas Argyll Robertson5 (1837-1909) was a Scottish Ophthalmologist and surgeon. Dr Robertson was the first to publish a description including post-op results following the use of a trephine in the surgical treatment of glaucoma in late 19th century. This would create a small hole in the sclera (anterior sclerotomy) that would drain aqueous Humor to lower IOP.

At the turn of the 20th Century, Dr Robert Henry Elliot6 (1865 – 1936) whom was a British ophthalmic surgeon and also an expert on snake venom published his work on Sclero-corneal trephining in the operative treatment of glaucoma

Read More

A Minimally invasive & Stent-less Treatment Glaucoma Innovation

At the forefront of Interventional Glaucoma treatment, MIMS® creates a direct pathway from the anterior chamber to the sub-conjunctival space during the surgery, without implanting a stent.

How MIMS® Works

It works by inserting a specially designed cutting tool into the sclera & removing a small channel of tissue. This channel will remain open & continuously drained, designed to effectively lower the IOP.

A Ready-to-Use Surgical System

MIMS® is a lightweight surgical system intended for use by trained professional ophthalmologists. It’s intuitive to operate and requires fewer staff to assist in non-surgical environments. A central control touchscreen demonstrates the surgical parameters & a foot pedal initiates the precise handheld cutting tool movement.

Precision Glaucoma Treatment Technology

Novel Glaucoma treatment practiced globally. Learn more about MIMS® surgical device innovation.

Download Specifications

Proven Clinical Performance


Medication reduction from baseline after 1 year1


IOP reduction from baseline after 1 and 3 years1-4


Medication reduction from baseline after 3 years2-4

Explore Clinical Outcomes

MIMS® Testimonials

News & Publications

Courtesy of Chrys Dimitriou, Colchester Eye Centre, Essex, UK
Learn More


1. Voskanyan L., Ahmed I.I.K., Gershoni A. et al., «Minimally invasive micro sclerostomy (MIMS) procedure in the treatment of open-angle glaucoma». BMC Ophthalmol 24, 122 (2024).

2. Voskanyan L. et al., « Long Term Results Of Minimally Invasive Micro Sclerostomy (MIMS®)»,10th World Glaucoma Congress, June 30, 2023, Rome Italy.

3. Voskanyan L., «Long-term results of Minimally Invasive Micro Sclerostomy (MIMS®)», Poster presented at the 41st Congress of the ESCRS, September 9, 2023, Vienna, Austria.

4. Geffen N., «Ab interno sclerostomy», Glaucoma Surgery: New Techniques on the Horizon,presented at the 10th Congress of the WGC Congress, June 30, 2023 Rome, Italy

5. Robertson D.A., «Trephining the sclerotic: a new operation for glaucoma.», Royal London Ophthalmic Hospital Reports, (Volume 8), 1876.

6. Elliot, R.H., «Sclero-corneal trephining in the operative treatment of glaucoma», 186 Pages, 2nd ed. London: George Pulman & Sons,1914.

7. Junemann A.G.M. and Redfak R., «MIMS – minimally invasive micro-sclerostomy: A new filtering surgical procedure.» Concept Ophtalmology, August 2022.

8. Grover D.S, MD, MPH, «MINIMALLY INVASIVE MICRO SCLEROSTOMY – Reviewing the surgical steps and outcomes for a new filtration procedure.», GLAUCOMA TODAY, 2022.

9. Larkin H., «Stent-less Glaucoma Surgery, Expanded indications sought for minimally invasive technology.», EUROTIME, 2023.

10. «MIMS®: WHERE NOTHING GETS LEFT BEHIND, Introducing a stentless, simple, and rapid glaucoma treatment that effectively lowers IOP without invasive surgery», The Ophtalmologist, 2022.

11. Voskanyan L., “New arrival – a fresh approach to treating glaucoma.” Presented at the 40th Congress of the ESCRS 2022 Congress, Bausch+Lomb Symposium, September 18, 2022; Milan, Italy.

12. Paper presented at the 40th Congress of the ESCRS 2022 Congress, Bausch+Lomb Symposium, September 18, 2022; Milan, Italy.